Evidence map›Paper›PMID 17290222›Full record

ArticleThe EMBO journal2007

Redirection of sphingolipid metabolism toward de novo synthesis of ethanolamine in Leishmania.

Kai Zhang, Justine M Pompey, Fong-Fu Hsu, Phillip Key, Padmavathi Bandhuvula, Julie D Saba, John Turk, Stephen M Beverley

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The EMBO journal, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Fatty Acid Profiles ofPathogens (Basel, Switzerland) · 2022
    Article
  10. The lipidome ofFrontiers in cellular and infection microbiology · 2022
    Article
  11. Lipid and fatty acid metabolism in trypanosomatids.Microbial cell (Graz, Austria) · 2021
    Review
  12. Review
  13. Article
  14. Article
  15. Frontiers in cellular and infection microbiology · 2021
    Article
  16. Article
  17. Lipids inFrontiers in cellular and infection microbiology · 2020
    Review
  18. Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis.Frontiers in cellular and infection microbiology · 2020
    Review
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kai ZhangDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110, and Children's Hospital Oakland Research Institute, Center for Cancer Research, CA, USA.
Justine M Pompey
Fong-Fu Hsu
Phillip Key
Padmavathi Bandhuvula
Julie D Saba
John Turk
Stephen M Beverley
Washington University in St. Louis · USOakland University · US

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Jonathan R Brestoff · 1999 to 2026
$30.2M
TRANSGENICS COREP60DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 1986 to 2012
$25.2M
YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTSP41RR000954 · NCRR · WASHINGTON UNIVERSITY · PI LIN, XI · 1985 to 2011
$16.0M
GLYCOSYLATION MUTANTS OF LEISHMANIAR01AI031078 · NIAID · WASHINGTON UNIVERSITY · PI BEVERLEY, STEPHEN M · 1992 to 2019
$11.4M
Sphingolipid Metabolism in Drosophila DevelopmentR01GM066954 · NIGMS · CHILDREN'S HOSPITAL &RES CTR AT OAKLAND · PI SABA, JULIE D · 2003 to 2013
$2.5M
NCRR NIH HHS P41 RR000954NCRR NIH HHS P41-RR00954NIAID NIH HHS AI31078NIAID NIH HHS R01 AI031078NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30-DK56341NIDDK NIH HHS P60 DK020579NIDDK NIH HHS P60-DK20579NIGMS NIH HHS GM66954NIGMS NIH HHS R01 GM066954NIGMS NIH HHS T32 GM00706PHS HHS R01-69455
6 · The paper itself

Abstract

In most eukaryotes, sphingolipids (SLs) are critical membrane components and signaling molecules. However, mutants of the trypanosomatid protozoan Leishmania lacking serine palmitoyltransferase (spt2-) and SLs grow well, although they are defective in stationary phase differentiation and virulence. Similar phenotypes were observed in sphingolipid (SL) mutant lacking the degradatory enzyme sphingosine 1-phosphate lyase (spl-). This epistatic interaction suggested that a metabolite downstream of SLs was responsible. Here we show that unlike other organisms, the Leishmania SL pathway has evolved to be the major route for ethanolamine (EtN) synthesis, as EtN supplementation completely reversed the viability and differentiation defects of both mutants. Thus Leishmania has undergone two major metabolic shifts: first in de-emphasizing the metabolic roles of SLs themselves in growth, signaling, and maintenance of membrane microdomains, which may arise from the unique combination of abundant parasite lipids; Second, freed of typical SL functional constraints and a lack of alternative routes to produce EtN, Leishmania redirected SL metabolism toward bulk EtN synthesis. Our results thus reveal a striking example of remodeling of the SL metabolic pathway in Leishmania.

Indexed as

Biological EvolutionAldehyde-LyasesAnimalsBase SequenceBiosynthetic PathwaysCloning, MolecularEthanolamineFemaleFootLeishmania majorMass SpectrometryMetabolic Networks and PathwaysMiceMice, Inbred BALB CMicroscopy, Electron, TransmissionMolecular Sequence DataAldehyde-LyasesEthanolamineSerine C-PalmitoyltransferaseSphingolipidssphingosine 1-phosphate lyase (aldolase)

Identifiers

PMID17290222
PMCPMC1852826
OpenAlexW2139138716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.